QLI - קפיטליזציית שוק Qilian International
The growth of Qilian International (QLI) is driven by the demand for Chinese medicine and agrochemicals, fueled by plant upgrades and expansion across Asia. Business success is constrained by PRC government control and raw material costs, while the market capitalization stands at 0.19. Historical price action clearly demonstrates the asset's market volatility. Steady interest in medical research transforms the company into a defensive asset, independent of global macroeconomic trends.
פילוחי מדדים ואנליטיקה של חברת Qilian International Corp (QLI)
The market capitalization dynamics of Qilian International (QLI) reflect investment expectations regarding the development of the pharmaceutical ecosystem in China. This indicator represents the aggregate result of discounting the issuer's future cash flows. The calculation is based on the product of the current share price and the total number of shares outstanding. For a business with limited capacity expansion due to environmental oversight, this metric measures the market margin of safety. High values confirm the capital's resilience to macroeconomic shocks.